{"disease":{"id":"refractory-ovarian-cancer-with-recurrent-symptomatic-malignant-ascites","name":"refractory ovarian cancer with recurrent symptomatic malignant ascites"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02540356","title":"Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}